VANCOUVER, BC and MESA, AZ, March 20, 2012 /PRNewswire/ - Asantae Holdings International Inc. (TSXV: JVA, OTC PINK: ASNHF) ("Asantae" or the "Company"), a producer and marketer of innovative nutritional products through a network of independent distributors, today recapped the recent media exposure that Dr. Dwight Lundell, author of "The Cure For Heart Disease" and formulator of Asantae's RealW8™, received on Fox News Channel and Rush Limbaugh's radio show. Dan Lundell, Asantae's CEO, stated that "Dr. Lundell's research and ideas have been central to Asantae's mission of addressing the root cause of obesity through our new lead product, RealW8™. Dr. Lundell is the driving force behind RealW8™ and has been instrumental to its successful launch to date." Asantae is also the publisher of Dr. Lundell's book, "The Cure for Heart Disease," which has recently moved into the Amazon best-seller category. To view Dr. Lundell's interviews on Fox News Channel, visit http://fxn.ws/wCLEF5 and http://bit.ly/A0uoyh. For a transcript of Rush Limbaugh's coverage of Dr. Lundell, visit http://bit.ly/zKjPwk. "The Cure for Heart Disease" is available for purchase at Amazon.com at http://amzn.to/zcCfHb. About Asantae Asantae Holdings International Inc. ( www.asantae.com) is a producer and marketer of innovative nutritional products through a network of independent distributors (Asantae Independent Affiliates). Asantae's flagship product RealW8™ addresses the primary threat to public health in the industrialized world; overweight and obesity. Asantae's approach to this threat is based on a body of research related to the brain chemistry of addiction, chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (obesity, heart disease, diabetes, stroke, some cancers, etc.). Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.